Metraipolis › archive › dc_bc51245461e2

Potential medical applicability of N-β-Ala and N-His dipeptidomimetics against breast cancer: short in vitro and in silico screening — Europe PMC PMID:42143112

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42143112
DOI: 10.1038/s41598-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-02T05:05:25.394Z
SHA-256 of the archived text: 2eb755f4d0e3bb8ff3391b75f5eddbbdcdb2f911f3fb1513e23d9c99247c89b1
Stable URL of this page: https://metraipolis.com/documento/dc_bc51245461e2

How to cite

Potential medical applicability of N-β-Ala and N-His dipeptidomimetics against breast cancer: short in vitro and in silico screening — Europe PMC PMID:42143112 — Europe PMC (en), https://europepmc.org/article/MED/42143112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc51245461e2 (Metraipolis archive dc_bc51245461e2, sha256 2eb755f4d0e3bb8ff3391b75f5eddbbdcdb2f911f3fb1513e23d9c99247c89b1)

BibTeX

@misc{dcbc51245461e2,
  title = {Potential medical applicability of N-β-Ala and N-His dipeptidomimetics against breast cancer: short in vitro and in silico screening — Europe PMC PMID:42143112},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42143112},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc51245461e2; sha256 2eb755f4d0e3bb8ff3391b75f5eddbbdcdb2f911f3fb1513e23d9c99247c89b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42143112. Agents can read the archived copy with the MCP tool read_document.